The Goldman Sachs Group Raises Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target to $33.00
Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) had its target price hoisted by The Goldman Sachs Group from $30.00 to $33.00 in a report released on Thursday,Benzinga reports. The firm currently has a buy rating on the stock. A number of other equities research analysts have also recently weighed in on SNDX. Citigroup lifted their price […]
More Stories
Rackspace Technology (NASDAQ:RXT) Releases Q4 Earnings Guidance
Rackspace Technology (NASDAQ:RXT – Get Free Report) issued an update on its fourth quarter earnings guidance on Tuesday morning. The...
Actelis Networks Reports Strong Financial Results for Q3 2024
Actelis Networks, Inc. (NASDAQ: ASNS) recently released its financial results for the fiscal third quarter ended September 30, 2024. The...
10,183 Shares in DexCom, Inc. (NASDAQ:DXCM) Purchased by Brooktree Capital Management
Brooktree Capital Management bought a new stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) during the 3rd quarter, according to...
Dyne Therapeutics (NASDAQ:DYN) Issues Quarterly Earnings Results, Misses Estimates By $0.25 EPS
Dyne Therapeutics (NASDAQ:DYN – Get Free Report) posted its earnings results on Tuesday. The company reported ($0.96) earnings per share...
Snider Financial Group Has $1.91 Million Holdings in Otis Worldwide Co. (NYSE:OTIS)
Snider Financial Group increased its stake in shares of Otis Worldwide Co. (NYSE:OTIS – Free Report) by 11.8% during the...
Stratasys (NASDAQ:SSYS) Sees Strong Trading Volume Following Analyst Upgrade
Stratasys Ltd. (NASDAQ:SSYS – Get Free Report) saw unusually-strong trading volume on Thursday after Needham & Company LLC raised their...